TAUNS Laboratories,Inc. 197AShort Interest
Estimated short interest in TAUNS Laboratories,Inc. (197A) is 2.30% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: UBS AG.
Estimated short interest
2.30%
±0.00%
Estimated position (shares)
2,460,400
As of 2026-11-18
Holders (0.5% or more)
1 firms
154 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2025-01-08 |
|---|---|
| Latest disclosure | 2026-11-10 (UBS AG, 2.30%) |
| Reporting institutions | 3 firms (154 reports) |
| Peak estimated short interest | 3.66% (2026-04-23, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- UBS AG
- GOLDMAN SACHS INTERNATIONAL
- Morgan Stanley MUFG Securities Co., Ltd.
2.30%
Estimated short interest, 2026-11-18
UBS AG2.30%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-10 | UBS AG | Position 2,460,400 shares | Ratio 2.30% | ▲0.10% | Holding |
| 2026-08-18 | GOLDMAN SACHS INTERNATIONAL | Position 519,200 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-09-14 | Morgan Stanley MUFG Securities Co., Ltd. | Position 473,524 shares | Ratio 0.44% | ▼0.15% | Below 0.5% |
Disclosure History 154 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-10 | UBS AG | Position 2,460,400 shares | Ratio 2.30% | ▲0.10% | — |
| 2026-10-07 | UBS AG | Position 2,355,400 shares | Ratio 2.20% | ▲0.02% | — |
| 2026-09-29 | UBS AG | Position 2,331,100 shares | Ratio 2.18% | ▼0.11% | — |
| 2026-09-16 | UBS AG | Position 2,450,000 shares | Ratio 2.29% | ▼0.09% | — |
| 2026-09-14 | Morgan Stanley MUFG Securities Co., Ltd. | Position 473,524 shares | Ratio 0.44% | ▼0.15% | Below 0.5% |
| 2026-09-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 637,824 shares | Ratio 0.59% | ▼0.09% | — |
| 2026-08-27 | Morgan Stanley MUFG Securities Co., Ltd. | Position 729,824 shares | Ratio 0.68% | ▼0.02% | — |
| 2026-08-25 | Morgan Stanley MUFG Securities Co., Ltd. | Position 748,424 shares | Ratio 0.70% | ▲0.10% | — |
| 2026-08-18 | GOLDMAN SACHS INTERNATIONAL | Position 519,200 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-08-18 | Morgan Stanley MUFG Securities Co., Ltd. | Position 642,224 shares | Ratio 0.60% | ▲0.02% | — |
| 2026-08-17 | UBS AG | Position 2,549,200 shares | Ratio 2.38% | ▼0.02% | — |
| 2026-08-14 | Morgan Stanley MUFG Securities Co., Ltd. | Position 623,424 shares | Ratio 0.58% | ▼0.02% | — |
| 2026-08-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 649,724 shares | Ratio 0.60% | ▲0.10% | — |
| 2026-07-31 | Morgan Stanley MUFG Securities Co., Ltd. | Position 536,224 shares | Ratio 0.50% | ▲0.05% | — |
| 2026-07-24 | UBS AG | Position 2,562,600 shares | Ratio 2.40% | ▲0.01% | — |
| 2026-07-13 | UBS AG | Position 2,554,300 shares | Ratio 2.39% | ▼0.02% | — |
| 2026-07-13 | GOLDMAN SACHS INTERNATIONAL | Position 541,300 shares | Ratio 0.50% | ▲0.08% | — |
| 2026-07-08 | UBS AG | Position 2,573,900 shares | Ratio 2.41% | ▲0.02% | — |
| 2026-07-06 | UBS AG | Position 2,557,500 shares | Ratio 2.39% | ▼0.01% | — |
| 2026-05-20 | UBS AG | Position 2,561,900 shares | Ratio 2.40% | ▲0.10% | — |
| 2026-05-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 520,040 shares | Ratio 0.48% | ▼0.07% | Below 0.5% |
| 2026-05-07 | GOLDMAN SACHS INTERNATIONAL | Position 481,400 shares | Ratio 0.45% | ▼0.14% | Below 0.5% |
| 2026-05-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 587,240 shares | Ratio 0.55% | ▼0.14% | — |
| 2026-04-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 735,240 shares | Ratio 0.69% | ▼0.08% | — |
| 2026-04-23 | Morgan Stanley MUFG Securities Co., Ltd. | Position 822,640 shares | Ratio 0.77% | ▲0.16% | — |
| 2026-04-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 655,240 shares | Ratio 0.61% | ▲0.02% | — |
| 2026-04-21 | UBS AG | Position 2,448,559 shares | Ratio 2.30% | ▲0.01% | — |
| 2026-04-20 | UBS AG | Position 2,448,246 shares | Ratio 2.29% | ▼0.04% | — |
| 2026-04-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 633,040 shares | Ratio 0.59% | ▼0.02% | — |
| 2026-04-14 | UBS AG | Position 2,483,500 shares | Ratio 2.33% | ▲0.05% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PRISM BioLab Co.,LTD206A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Heartseed Inc.219A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |